Linking to longevity

The low correlation between mortality and returns on most asset classes means that US-traded life settlement policies are a marketable underlying. But while trading longevity risk is set to rise among institutions, some structured products providers are unwilling to offer mortality-linked investments to retail investors. By Amanda Lee

A report by US investment research firm Bernstein Research predicts that the life settlement market in the US (see box page 26) could grow from $13 billion as of 2004 to $160 billion by 2030, possibly even sooner. The report also estimates that life settlements can provide an internal rate of return of between 9% and 13%.

For financial institutions, including structured products providers, the fact that these contracts are traded in a secondary market means there is sufficient liquidity to tap

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here